Approval · Notice of Compliance 30120 · 2023
FROVA: Notice of Compliance 30120
Issued February 14, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30120
- Date
- February 14, 2023
- Company
- Endo Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Convert the Product Monograph (PM) to the 2020 master template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FROVA | Not yet assigned | — |
Medicinal ingredients
- FROVATRIPTAN SUCCINATE 2.5 MG per TAB